Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
The life sciences industry is in the middle of a digital transformation, with companies of all sizes racing to seek innovative solutions that will help them to stay ahead of the curve. One of the most promising solutions on the horizon is the concept of a hyper-automated AI ecosystem.
The field of data science has seen explosive growth over the years, expanding beyond statistical problem-solving to addressing real-world issues and creating reliable fact-driven predictions across industries. In fact, data and analytics leaders who share data externally end up generating three times more measurable economic benefits vis-à-vis those who don’t, per Gartner1.
How can pharma companies tackle therapy nonadherence effectively? Pharma companies lose $600+ billion each year due to patients not taking their medications. We present five strategies that can help them improve the return on investment from their adherence promoting initiatives and drive positive health outcomes for patients. 1. Personalization of solutions through AI and data-driven segmentation Patients face diverse barriers to take their medications as they go through the treatment.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
